Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett's esophagus with or without early esophageal neoplasia : a systematic review and meta-analysis
BACKGROUND/AIMS: Radiofrequency ablation (RFA) is the first-line therapy for dysplastic Barrett's esophagus (BE). Therefore, cryotherapy has emerged as an alternative treatment option. This study aimed to compare the efficacies of these two techniques based on the rates of complete eradication of intestinal metaplasia (CE-IM) and dysplasia (CE-D). Adverse events and recurrence have also been reported.
METHODS: An electronic search was conducted using the Medline (PubMed), Embase, LILACS, and Google Scholar databases until December 2022. Studies were included comparing cryotherapy and RFA for treating dysplastic BE with or without early esophageal neoplasia. This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
RESULTS: Three retrospective cohort studies involving 627 patients were included. Of these, 399 patients underwent RFA, and 228 were treated with cryotherapy. There was no difference in CE-IM (risk difference [RD], -0.03; 95% confidence interval [CI], -0.25 to 0.19; p=0.78; I2=86%) as well as in CE-D (RD, -0.03; 95% CI, -0.15 to 0.09; p=0.64; I2=70%) between the groups. The absolute number of adverse events was low, and there was no difference in the recurrence rate.
CONCLUSION: Cryotherapy and RFA were equally effective in treating dysplastic BE, with or without early esophageal neoplasia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Clinical endoscopy - 57(2024), 2 vom: 01. März, Seite 181-190 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gomes, Igor Logetto Caetité [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Barrett esophagus |
|---|
| Anmerkungen: |
Date Revised 04.04.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5946/ce.2023.065 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367199963 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367199963 | ||
| 003 | DE-627 | ||
| 005 | 20240404234617.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240117s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5946/ce.2023.065 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM367199963 | ||
| 035 | |a (NLM)38229440 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gomes, Igor Logetto Caetité |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett's esophagus with or without early esophageal neoplasia |b a systematic review and meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a BACKGROUND/AIMS: Radiofrequency ablation (RFA) is the first-line therapy for dysplastic Barrett's esophagus (BE). Therefore, cryotherapy has emerged as an alternative treatment option. This study aimed to compare the efficacies of these two techniques based on the rates of complete eradication of intestinal metaplasia (CE-IM) and dysplasia (CE-D). Adverse events and recurrence have also been reported | ||
| 520 | |a METHODS: An electronic search was conducted using the Medline (PubMed), Embase, LILACS, and Google Scholar databases until December 2022. Studies were included comparing cryotherapy and RFA for treating dysplastic BE with or without early esophageal neoplasia. This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines | ||
| 520 | |a RESULTS: Three retrospective cohort studies involving 627 patients were included. Of these, 399 patients underwent RFA, and 228 were treated with cryotherapy. There was no difference in CE-IM (risk difference [RD], -0.03; 95% confidence interval [CI], -0.25 to 0.19; p=0.78; I2=86%) as well as in CE-D (RD, -0.03; 95% CI, -0.15 to 0.09; p=0.64; I2=70%) between the groups. The absolute number of adverse events was low, and there was no difference in the recurrence rate | ||
| 520 | |a CONCLUSION: Cryotherapy and RFA were equally effective in treating dysplastic BE, with or without early esophageal neoplasia | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Barrett esophagus | |
| 650 | 4 | |a Cryotherapy | |
| 650 | 4 | |a Radiofrequency ablation | |
| 700 | 1 | |a de Moura, Diogo Turiani Hourneaux |e verfasserin |4 aut | |
| 700 | 1 | |a Ribeiro, Igor Braga |e verfasserin |4 aut | |
| 700 | 1 | |a Marques, Sérgio Barbosa |e verfasserin |4 aut | |
| 700 | 1 | |a de Sousa Carlos, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Nunes, Beanie Conceição Medeiros |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, Bruno Salomão |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira, Guilherme Henrique Peixoto |e verfasserin |4 aut | |
| 700 | 1 | |a Trasolini, Roberto Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Bernardo, Wanderley Marques |e verfasserin |4 aut | |
| 700 | 1 | |a de Moura, Eduardo Guimarães Hourneaux |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical endoscopy |d 2011 |g 57(2024), 2 vom: 01. März, Seite 181-190 |w (DE-627)NLM218997000 |x 2234-2400 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2024 |g number:2 |g day:01 |g month:03 |g pages:181-190 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5946/ce.2023.065 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2024 |e 2 |b 01 |c 03 |h 181-190 | ||